StockData
Enovis CORP logo

Enovis CORP (ENOV) stock

ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)

Close on Nov 18, 2026Market cap $1.56BP/E –Yield –

Enovis operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Enovis's operating cash flow for the twelve months ending Jul 3, 2026 was $270.10M, up 43.6% year over year. For fiscal 2025 it was $217.29M, up 91.4% from the year before. Over ten years it grew -3.3% a year on average. The highest annual figure on record is $385.76M in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$217.29M+91.4%
FY2024Dec 31, 2024$113.50M-15.9%
FY2023Dec 31, 2023$134.99M–
FY2022Dec 31, 2022-$55.86M-115.7%
FY2021Dec 31, 2021$356.10M+17.9%
FY2020Dec 31, 2020$301.94M+130.6%
FY2019Dec 31, 2019$130.95M-42.2%
FY2018Dec 31, 2018$226.37M+3.5%
FY2017Dec 31, 2017$218.77M-11.4%
FY2016Dec 31, 2016$246.97M-18.7%
FY2015Dec 31, 2015$303.81M-21.2%
FY2014Dec 31, 2014$385.76M+6.5%
FY2013Dec 31, 2013$362.17M+108.1%
FY2012Dec 31, 2012$174.02M+204.5%
FY2011Dec 31, 2011$57.15M-7.8%
FY2010Dec 31, 2010$61.97M+60.1%
FY2009Dec 31, 2009$38.70M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jul 3, 2026$75.03M+57.1%
Q1 FY2026Apr 3, 2026$23.95M–
Q4 FY2025Dec 31, 2025$88.54M+0.2%
Q3 FY2025Oct 3, 2025$82.58M+54.2%
Q2 FY2025Jul 4, 2025$47.77M+514.6%
Q1 FY2025Apr 4, 2025-$1.60M–
Q4 FY2024Dec 31, 2024$88.33M+29.1%
Q3 FY2024Sep 27, 2024$53.56M+72.7%
Q2 FY2024Jun 28, 2024$7.77M-72.3%
Q1 FY2024Mar 29, 2024-$36.16M-584.9%
Q4 FY2023Dec 31, 2023$68.42M–
Q3 FY2023Sep 29, 2023$31.01M+59.8%
Q2 FY2023Jun 30, 2023$28.10M–
Q1 FY2023Mar 31, 2023$7.46M–
Q4 FY2022Dec 31, 2022-$35.96M-137.4%
Q3 FY2022Sep 30, 2022$19.41M-80.0%
Q2 FY2022Jul 1, 2022-$24.89M-131.8%
Q1 FY2022Apr 1, 2022-$14.42M-117.1%
Q4 FY2021Dec 31, 2021$96.22M-25.3%
Q3 FY2021Oct 1, 2021$97.13M+21.5%
Q2 FY2021Jul 2, 2021$78.37M+111.9%
Q1 FY2021Apr 2, 2021$84.38M+50.1%
Q4 FY2020Dec 31, 2020$128.80M+97.6%
Q3 FY2020Oct 2, 2020$79.92M+44.5%
Q2 FY2020Jul 3, 2020$36.99M-55.3%
Q1 FY2020Apr 3, 2020$56.23M–
Q4 FY2019Dec 31, 2019$65.20M-48.1%
Q3 FY2019Sep 27, 2019$55.32M-17.6%
Q2 FY2019Jun 28, 2019$82.72M+127.8%
Q1 FY2019Mar 29, 2019-$72.29M–
Q4 FY2018Dec 31, 2018$125.56M+20.6%
Q3 FY2018Sep 28, 2018$67.15M+316.2%
Q2 FY2018Jun 29, 2018$36.32M-37.5%
Q1 FY2018Mar 31, 2018-$2.66M-106.6%
Q4 FY2017Dec 31, 2017$104.08M-28.3%
Q3 FY2017Sep 29, 2017$16.13M-64.5%
Q2 FY2017Jun 30, 2017$58.15M–
Q1 FY2017Mar 31, 2017$40.41M–
Q4 FY2016Dec 31, 2016$145.12M–
Q3 FY2016Sep 30, 2016$45.44M–

More Enovis figures

See a number that looks wrong?